Rank | Gene Set | Z-score |
---|---|---|
1 | immunoglobulin mediated immune response (GO:0016064) | 6.69671351 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.30148782 |
3 | B cell mediated immunity (GO:0019724) | 5.24233970 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.00358341 |
5 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 4.98092437 |
6 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.95969268 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.79383875 |
8 | regulation of antigen processing and presentation (GO:0002577) | 4.73260113 |
9 | detection of bacterium (GO:0016045) | 4.66437895 |
10 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.58522116 |
11 | detection of other organism (GO:0098543) | 4.56823582 |
12 | positive regulation of antigen processing and presentation (GO:0002579) | 4.56456107 |
13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55715683 |
14 | neutrophil activation involved in immune response (GO:0002283) | 4.51777925 |
15 | positive thymic T cell selection (GO:0045059) | 4.35225198 |
16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32742157 |
17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.31395483 |
18 | negative regulation of cell killing (GO:0031342) | 4.20588520 |
19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.20588520 |
20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17425688 |
21 | modulation by symbiont of host defense response (GO:0052031) | 4.17425688 |
22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17425688 |
23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17425688 |
24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17425688 |
25 | modulation by symbiont of host immune response (GO:0052553) | 4.17425688 |
26 | T-helper 1 type immune response (GO:0042088) | 4.14883809 |
27 | response to peptidoglycan (GO:0032494) | 4.08072066 |
28 | macrophage activation involved in immune response (GO:0002281) | 4.01544786 |
29 | * cellular response to interferon-gamma (GO:0071346) | 3.91329187 |
30 | B cell receptor signaling pathway (GO:0050853) | 3.77637529 |
31 | negative regulation of interleukin-12 production (GO:0032695) | 3.76578281 |
32 | detection of external biotic stimulus (GO:0098581) | 3.69029985 |
33 | positive regulation of type 2 immune response (GO:0002830) | 3.68754292 |
34 | * T cell costimulation (GO:0031295) | 3.65145136 |
35 | type I interferon signaling pathway (GO:0060337) | 3.64121392 |
36 | cellular response to type I interferon (GO:0071357) | 3.64121392 |
37 | response to type I interferon (GO:0034340) | 3.61428768 |
38 | positive regulation of mast cell activation (GO:0033005) | 3.60817896 |
39 | * lymphocyte costimulation (GO:0031294) | 3.59734952 |
40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57597604 |
41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.55844823 |
42 | * response to interferon-gamma (GO:0034341) | 3.54412824 |
43 | positive regulation of B cell differentiation (GO:0045579) | 3.52947447 |
44 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51128383 |
45 | positive regulation of mast cell degranulation (GO:0043306) | 3.51128383 |
46 | defense response to protozoan (GO:0042832) | 3.51073541 |
47 | regulation of mast cell degranulation (GO:0043304) | 3.41896118 |
48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.40851155 |
49 | response to protozoan (GO:0001562) | 3.28819047 |
50 | positive T cell selection (GO:0043368) | 3.27517353 |
51 | myeloid cell activation involved in immune response (GO:0002275) | 3.26357030 |
52 | myeloid dendritic cell activation (GO:0001773) | 3.23097810 |
53 | microglial cell activation (GO:0001774) | 3.23084566 |
54 | detection of biotic stimulus (GO:0009595) | 3.22938084 |
55 | regulation of mast cell activation (GO:0033003) | 3.20994417 |
56 | negative thymic T cell selection (GO:0045060) | 3.20308886 |
57 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.16410996 |
58 | regulation of T cell tolerance induction (GO:0002664) | 3.16128359 |
59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16082070 |
60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.15730832 |
61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.12534908 |
62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.09957412 |
63 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.08710076 |
64 | regulation of B cell differentiation (GO:0045577) | 3.08457128 |
65 | myeloid dendritic cell differentiation (GO:0043011) | 3.07247641 |
66 | regulation of hypersensitivity (GO:0002883) | 3.06350931 |
67 | production of molecular mediator of immune response (GO:0002440) | 3.06289297 |
68 | regulation of interferon-alpha production (GO:0032647) | 3.04487975 |
69 | NIK/NF-kappaB signaling (GO:0038061) | 3.04122032 |
70 | positive regulation of interferon-alpha production (GO:0032727) | 3.03536096 |
71 | response to host immune response (GO:0052572) | 3.01004314 |
72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.01004314 |
73 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00238980 |
74 | negative T cell selection (GO:0043383) | 2.98492792 |
75 | germinal center formation (GO:0002467) | 2.97881026 |
76 | regulation of tolerance induction (GO:0002643) | 2.97611678 |
77 | T cell selection (GO:0045058) | 2.96550873 |
78 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.94109376 |
79 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.94051461 |
80 | T cell migration (GO:0072678) | 2.93672069 |
81 | response to muramyl dipeptide (GO:0032495) | 2.91744471 |
82 | neutrophil activation (GO:0042119) | 2.90374281 |
83 | thymic T cell selection (GO:0045061) | 2.89935085 |
84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.89360021 |
85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88145929 |
86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.88137276 |
87 | granulocyte activation (GO:0036230) | 2.87489841 |
88 | detection of molecule of bacterial origin (GO:0032490) | 2.86780589 |
89 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86735490 |
90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86229176 |
91 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84728971 |
92 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.83636520 |
93 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83603798 |
94 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.81593233 |
95 | respiratory burst (GO:0045730) | 2.81492127 |
96 | macrophage activation (GO:0042116) | 2.81220128 |
97 | regulation of leukocyte degranulation (GO:0043300) | 2.79982918 |
98 | regulation of type 2 immune response (GO:0002828) | 2.78759251 |
99 | adaptive immune response (GO:0002250) | 2.76690920 |
100 | cellular extravasation (GO:0045123) | 2.75721959 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.61088915 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.99419079 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.83294656 |
4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.02753822 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.52757512 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.42820540 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16387135 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16124924 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.15933908 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08969482 |
11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86533836 |
12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65159592 |
13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55897914 |
14 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.52206587 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44941150 |
16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.43660101 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42483132 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38375118 |
19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38072507 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29794447 |
21 | MYB_26560356_Chip-Seq_TH2_Human | 2.27293201 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26385477 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25237132 |
24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23186416 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21228306 |
26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.20518732 |
27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16207134 |
28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.09362805 |
29 | MYC_22102868_ChIP-Seq_BL_Human | 2.03597191 |
30 | MAF_26560356_Chip-Seq_TH1_Human | 1.98036665 |
31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95441955 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86591110 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86391892 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86059065 |
35 | MYB_26560356_Chip-Seq_TH1_Human | 1.84456380 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77138941 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74335928 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67052475 |
39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62000788 |
40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60108453 |
41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56721197 |
42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55504248 |
43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55052040 |
44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53111405 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51655810 |
46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47775798 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43259500 |
48 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36334254 |
49 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36146352 |
50 | MAF_26560356_Chip-Seq_TH2_Human | 1.35754459 |
51 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34225262 |
52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.29757218 |
53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28928892 |
54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27880845 |
55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27342782 |
56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25999187 |
57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25110495 |
58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24771016 |
59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23389176 |
60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23138471 |
61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21437792 |
62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21398346 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20859099 |
64 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18642471 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17653551 |
66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16703439 |
67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15964267 |
68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.14002288 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13723860 |
70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13148546 |
71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12412488 |
72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11165924 |
73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10455508 |
74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08004030 |
75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06367383 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05882637 |
77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05214028 |
78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98845136 |
79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95201501 |
80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95109767 |
81 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95081762 |
82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95003976 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93995249 |
84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91292036 |
85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90716269 |
86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90603074 |
87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89648625 |
88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89042945 |
89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87463958 |
90 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86697489 |
91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86471451 |
92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86204246 |
93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83134628 |
94 | P300_27268052_Chip-Seq_Bcells_Human | 0.82762335 |
95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81267541 |
96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78208273 |
97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76161963 |
98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74267456 |
99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74245443 |
100 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72430730 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.90962515 |
2 | MP0005671_abnormal_response_to | 3.75299521 |
3 | MP0003303_peritoneal_inflammation | 3.63081056 |
4 | MP0003724_increased_susceptibility_to | 3.43578611 |
5 | MP0003436_decreased_susceptibility_to | 3.32220156 |
6 | MP0005387_immune_system_phenotype | 3.26442638 |
7 | MP0001790_abnormal_immune_system | 3.26442638 |
8 | MP0001800_abnormal_humoral_immune | 3.19942427 |
9 | MP0000685_abnormal_immune_system | 3.17610622 |
10 | MP0002148_abnormal_hypersensitivity_rea | 3.05947526 |
11 | MP0005000_abnormal_immune_tolerance | 3.05564369 |
12 | MP0009785_altered_susceptibility_to | 3.01854137 |
13 | MP0005025_abnormal_response_to | 2.82822148 |
14 | MP0002419_abnormal_innate_immunity | 2.81201082 |
15 | MP0002452_abnormal_antigen_presenting | 2.80883049 |
16 | MP0006082_CNS_inflammation | 2.72117708 |
17 | MP0002723_abnormal_immune_serum | 2.68569138 |
18 | MP0002420_abnormal_adaptive_immunity | 2.46661335 |
19 | MP0001819_abnormal_immune_cell | 2.45913973 |
20 | MP0005058_abnormal_lysosome_morphology | 2.23976048 |
21 | MP0010155_abnormal_intestine_physiology | 2.23705814 |
22 | MP0005464_abnormal_platelet_physiology | 2.01268293 |
23 | MP0003300_gastrointestinal_ulcer | 1.98194197 |
24 | MP0003172_abnormal_lysosome_physiology | 1.94520553 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.91612228 |
26 | MP0001845_abnormal_inflammatory_respons | 1.90151093 |
27 | MP0000716_abnormal_immune_system | 1.87015832 |
28 | MP0003763_abnormal_thymus_physiology | 1.79567644 |
29 | MP0002398_abnormal_bone_marrow | 1.78975474 |
30 | MP0001533_abnormal_skeleton_physiology | 1.77621331 |
31 | MP0002405_respiratory_system_inflammati | 1.76207823 |
32 | MP0009764_decreased_sensitivity_to | 1.72145864 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.71312592 |
34 | MP0003075_altered_response_to | 1.70002019 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.66990792 |
36 | MP0003183_abnormal_peptide_metabolism | 1.62357632 |
37 | MP0004947_skin_inflammation | 1.62212644 |
38 | MP0003806_abnormal_nucleotide_metabolis | 1.61987192 |
39 | MP0002166_altered_tumor_susceptibility | 1.61060153 |
40 | MP0008469_abnormal_protein_level | 1.59434544 |
41 | MP0001853_heart_inflammation | 1.53802883 |
42 | MP0000689_abnormal_spleen_morphology | 1.50599621 |
43 | MP0002429_abnormal_blood_cell | 1.47344482 |
44 | MP0005166_decreased_susceptibility_to | 1.46018007 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.44043835 |
46 | MP0009840_abnormal_foam_cell | 1.42829094 |
47 | MP0009278_abnormal_bone_marrow | 1.40581032 |
48 | MP0003866_abnormal_defecation | 1.39157682 |
49 | MP0001545_abnormal_hematopoietic_system | 1.39075515 |
50 | MP0005397_hematopoietic_system_phenotyp | 1.39075515 |
51 | MP0005310_abnormal_salivary_gland | 1.38950101 |
52 | MP0000465_gastrointestinal_hemorrhage | 1.38142540 |
53 | MP0002722_abnormal_immune_system | 1.34257982 |
54 | MP0000343_altered_response_to | 1.33767690 |
55 | MP0005451_abnormal_body_composition | 1.32601421 |
56 | MP0001873_stomach_inflammation | 1.30491369 |
57 | MP0002998_abnormal_bone_remodeling | 1.29629957 |
58 | MP0000858_altered_metastatic_potential | 1.20526669 |
59 | MP0000604_amyloidosis | 1.19011869 |
60 | MP0002006_tumorigenesis | 1.09516557 |
61 | MP0008004_abnormal_stomach_pH | 1.08507599 |
62 | MP0004510_myositis | 1.02311353 |
63 | MP0001663_abnormal_digestive_system | 0.98758329 |
64 | MP0003448_altered_tumor_morphology | 0.96094368 |
65 | MP0002396_abnormal_hematopoietic_system | 0.92358841 |
66 | MP0009763_increased_sensitivity_to | 0.92241347 |
67 | MP0003828_pulmonary_edema | 0.92120286 |
68 | MP0000703_abnormal_thymus_morphology | 0.89968432 |
69 | MP0008260_abnormal_autophagy | 0.86746528 |
70 | MP0000249_abnormal_blood_vessel | 0.84516988 |
71 | MP0003690_abnormal_glial_cell | 0.82315509 |
72 | MP0005075_abnormal_melanosome_morpholog | 0.81372834 |
73 | MP0001851_eye_inflammation | 0.81273674 |
74 | MP0004883_abnormal_blood_vessel | 0.78763441 |
75 | MP0005165_increased_susceptibility_to | 0.78553005 |
76 | MP0002933_joint_inflammation | 0.78149790 |
77 | MP0000490_abnormal_crypts_of | 0.76577848 |
78 | MP0005167_abnormal_blood-brain_barrier | 0.71656945 |
79 | MP0002132_abnormal_respiratory_system | 0.70981690 |
80 | MP0005390_skeleton_phenotype | 0.70844003 |
81 | MP0005164_abnormal_response_to | 0.67885852 |
82 | MP0009765_abnormal_xenobiotic_induced | 0.65237140 |
83 | MP0002136_abnormal_kidney_physiology | 0.65085603 |
84 | MP0000015_abnormal_ear_pigmentation | 0.63818599 |
85 | MP0005365_abnormal_bile_salt | 0.62626105 |
86 | MP0009643_abnormal_urine_homeostasis | 0.61475691 |
87 | MP0003795_abnormal_bone_structure | 0.60479745 |
88 | MP0003045_fibrosis | 0.60302577 |
89 | MP0004808_abnormal_hematopoietic_stem | 0.59868884 |
90 | MP0000920_abnormal_myelination | 0.59661080 |
91 | MP0005319_abnormal_enzyme/_coenzyme | 0.58606666 |
92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58517415 |
93 | MP0005381_digestive/alimentary_phenotyp | 0.57190557 |
94 | MP0008874_decreased_physiological_sensi | 0.55406024 |
95 | MP0005360_urolithiasis | 0.54979412 |
96 | MP0005535_abnormal_body_temperature | 0.53486828 |
97 | MP0000609_abnormal_liver_physiology | 0.53355433 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.51879282 |
99 | MP0003091_abnormal_cell_migration | 0.51014233 |
100 | MP0002019_abnormal_tumor_incidence | 0.49485725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.98028909 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.95624228 |
3 | Recurrent abscess formation (HP:0002722) | 4.83247860 |
4 | Abnormality of macrophages (HP:0004311) | 4.61126754 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.45075501 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 4.34863392 |
7 | Agammaglobulinemia (HP:0004432) | 4.26374344 |
8 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.16496739 |
9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.16496739 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.16496739 |
11 | * Meningitis (HP:0001287) | 4.15908240 |
12 | Myositis (HP:0100614) | 3.82424579 |
13 | Recurrent fungal infections (HP:0002841) | 3.82067568 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76706002 |
15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.72187235 |
16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.71296661 |
17 | * Vasculitis (HP:0002633) | 3.65218070 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.61202816 |
19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.61202816 |
20 | Recurrent skin infections (HP:0001581) | 3.57810322 |
21 | Orchitis (HP:0100796) | 3.51844087 |
22 | Gastrointestinal stroma tumor (HP:0100723) | 3.48377272 |
23 | Panhypogammaglobulinemia (HP:0003139) | 3.44770137 |
24 | Optic neuritis (HP:0100653) | 3.43910345 |
25 | Retrobulbar optic neuritis (HP:0100654) | 3.43910345 |
26 | Urticaria (HP:0001025) | 3.41231100 |
27 | Recurrent viral infections (HP:0004429) | 3.40335292 |
28 | Increased cerebral lipofuscin (HP:0011813) | 3.38974571 |
29 | * Obstructive lung disease (HP:0006536) | 3.35363012 |
30 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.35363012 |
31 | Colitis (HP:0002583) | 3.26064659 |
32 | Gastrointestinal infarctions (HP:0005244) | 3.20623401 |
33 | Cellulitis (HP:0100658) | 3.16588612 |
34 | * Pulmonary infiltrates (HP:0002113) | 3.13582278 |
35 | Vacuolated lymphocytes (HP:0001922) | 3.11798745 |
36 | Encephalitis (HP:0002383) | 3.05627506 |
37 | Stomatitis (HP:0010280) | 3.00591655 |
38 | Recurrent bronchitis (HP:0002837) | 2.99006640 |
39 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.97989803 |
40 | Inflammation of the large intestine (HP:0002037) | 2.95382976 |
41 | Recurrent sinusitis (HP:0011108) | 2.95331947 |
42 | Increased IgE level (HP:0003212) | 2.89705737 |
43 | Spontaneous hematomas (HP:0007420) | 2.87420426 |
44 | Dysostosis multiplex (HP:0000943) | 2.86463443 |
45 | Increased IgM level (HP:0003496) | 2.84997825 |
46 | Autoimmune thrombocytopenia (HP:0001973) | 2.84969938 |
47 | Gastrointestinal inflammation (HP:0004386) | 2.79650105 |
48 | * Hemoptysis (HP:0002105) | 2.75211490 |
49 | Petechiae (HP:0000967) | 2.71242629 |
50 | Purpura (HP:0000979) | 2.68760616 |
51 | Chronic diarrhea (HP:0002028) | 2.68023632 |
52 | Loss of speech (HP:0002371) | 2.67511225 |
53 | Osteomyelitis (HP:0002754) | 2.63557758 |
54 | Abnormality of T cell number (HP:0011839) | 2.60814199 |
55 | T lymphocytopenia (HP:0005403) | 2.56190221 |
56 | Gingivitis (HP:0000230) | 2.54165345 |
57 | Pustule (HP:0200039) | 2.53664240 |
58 | Lymphopenia (HP:0001888) | 2.52320365 |
59 | Keratoconjunctivitis sicca (HP:0001097) | 2.51214584 |
60 | Abnormality of T cells (HP:0002843) | 2.50796069 |
61 | IgM deficiency (HP:0002850) | 2.49923393 |
62 | Glomerulonephritis (HP:0000099) | 2.49056549 |
63 | Recurrent pneumonia (HP:0006532) | 2.46971176 |
64 | * Restrictive lung disease (HP:0002091) | 2.45268684 |
65 | Amyloidosis (HP:0011034) | 2.44682970 |
66 | Abnormality of B cell number (HP:0010975) | 2.44537834 |
67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.42318921 |
68 | Hypergammaglobulinemia (HP:0010702) | 2.41620805 |
69 | Abnormality of T cell physiology (HP:0011840) | 2.37072327 |
70 | Emphysema (HP:0002097) | 2.36663086 |
71 | Recurrent lower respiratory tract infections (HP:0002783) | 2.34373619 |
72 | * Abnormality of the pleura (HP:0002103) | 2.34224580 |
73 | Chronic otitis media (HP:0000389) | 2.32693487 |
74 | Keratoconjunctivitis (HP:0001096) | 2.32575976 |
75 | Disinhibition (HP:0000734) | 2.31603254 |
76 | * Chest pain (HP:0100749) | 2.30902884 |
77 | Hypertensive crisis (HP:0100735) | 2.30255755 |
78 | Leukocytosis (HP:0001974) | 2.28457653 |
79 | Xerostomia (HP:0000217) | 2.24694414 |
80 | Arterial thrombosis (HP:0004420) | 2.24665315 |
81 | * Skin rash (HP:0000988) | 2.22946304 |
82 | Gingival bleeding (HP:0000225) | 2.20055421 |
83 | Papilloma (HP:0012740) | 2.19581589 |
84 | Verrucae (HP:0200043) | 2.19581589 |
85 | Acrocyanosis (HP:0001063) | 2.19304597 |
86 | Abnormality of complement system (HP:0005339) | 2.19052112 |
87 | Granulocytopenia (HP:0001913) | 2.18981625 |
88 | IgG deficiency (HP:0004315) | 2.18584369 |
89 | Prolonged bleeding time (HP:0003010) | 2.16627255 |
90 | Autoimmune hemolytic anemia (HP:0001890) | 2.14448752 |
91 | * Epistaxis (HP:0000421) | 2.13224252 |
92 | Sepsis (HP:0100806) | 2.11250655 |
93 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10339776 |
94 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10339776 |
95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10339776 |
96 | Hepatosplenomegaly (HP:0001433) | 2.09921450 |
97 | B lymphocytopenia (HP:0010976) | 2.07612720 |
98 | Premature loss of primary teeth (HP:0006323) | 2.06966587 |
99 | IgA deficiency (HP:0002720) | 2.06740808 |
100 | Malnutrition (HP:0004395) | 2.06382804 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 4.45424218 |
2 | MAP4K1 | 4.30758317 |
3 | BLK | 3.70817966 |
4 | TYK2 | 2.99914873 |
5 | BMPR2 | 2.78550170 |
6 | MAP3K14 | 2.69514023 |
7 | KIT | 2.62242053 |
8 | ERN1 | 2.59133304 |
9 | CSF1R | 2.50620693 |
10 | SYK | 2.33282454 |
11 | TBK1 | 2.29374817 |
12 | JAK3 | 2.22622295 |
13 | FES | 2.17177123 |
14 | IRAK4 | 2.12280242 |
15 | BTK | 2.01165079 |
16 | CSK | 1.99465591 |
17 | IKBKE | 1.98089177 |
18 | MAP3K13 | 1.95532682 |
19 | IKBKB | 1.92503392 |
20 | PRPF4B | 1.87808196 |
21 | TXK | 1.83133176 |
22 | LYN | 1.77322548 |
23 | TAOK3 | 1.70026963 |
24 | ZAP70 | 1.66646810 |
25 | CDK19 | 1.62415371 |
26 | MATK | 1.59247638 |
27 | JAK1 | 1.53217737 |
28 | MAP2K3 | 1.49368886 |
29 | TEC | 1.42846149 |
30 | TNK2 | 1.36381537 |
31 | GRK6 | 1.36248704 |
32 | ITK | 1.35958826 |
33 | HCK | 1.35938861 |
34 | FGR | 1.34277222 |
35 | LCK | 1.29834194 |
36 | NME2 | 1.27631241 |
37 | GRK7 | 1.23426827 |
38 | MAP3K11 | 1.13154705 |
39 | JAK2 | 1.09504660 |
40 | MAP3K3 | 1.07340778 |
41 | SIK3 | 1.06822593 |
42 | CDC42BPA | 1.00476036 |
43 | TLK1 | 0.95163804 |
44 | IRAK3 | 0.92052689 |
45 | TGFBR2 | 0.91578839 |
46 | TAOK2 | 0.90348661 |
47 | KDR | 0.86187406 |
48 | MARK3 | 0.83606223 |
49 | TESK2 | 0.83053877 |
50 | PRKCQ | 0.80774780 |
51 | MAP3K1 | 0.78029629 |
52 | PDK1 | 0.75371353 |
53 | PIK3CG | 0.72062520 |
54 | MAPK7 | 0.69036218 |
55 | TAOK1 | 0.68213517 |
56 | SIK2 | 0.65513384 |
57 | CHUK | 0.64416507 |
58 | RIPK1 | 0.62711172 |
59 | MAPK12 | 0.61822562 |
60 | PIM1 | 0.59318758 |
61 | PDPK1 | 0.57718419 |
62 | FGFR3 | 0.55611268 |
63 | FYN | 0.54520386 |
64 | ABL1 | 0.53008492 |
65 | HIPK2 | 0.52719852 |
66 | ACVR1B | 0.52211682 |
67 | STK10 | 0.50684499 |
68 | ADRBK2 | 0.50571154 |
69 | FGFR4 | 0.49855367 |
70 | IRAK1 | 0.49106386 |
71 | DDR2 | 0.46693993 |
72 | DAPK3 | 0.46271647 |
73 | MAPK11 | 0.44832964 |
74 | TRPM7 | 0.44670726 |
75 | PIM2 | 0.44649339 |
76 | LRRK2 | 0.43732646 |
77 | PRKCD | 0.41530776 |
78 | RPS6KC1 | 0.39382683 |
79 | RPS6KL1 | 0.39382683 |
80 | CDK4 | 0.38451582 |
81 | EGFR | 0.36291998 |
82 | MAP2K6 | 0.36108676 |
83 | MAP3K5 | 0.35653994 |
84 | SMG1 | 0.35368346 |
85 | EPHB1 | 0.35171913 |
86 | MAPK4 | 0.34893746 |
87 | MAPKAPK2 | 0.34046974 |
88 | CDK6 | 0.33755128 |
89 | RPS6KA6 | 0.33458425 |
90 | IGF1R | 0.32495999 |
91 | MAP3K10 | 0.31241873 |
92 | MOS | 0.29701663 |
93 | BCKDK | 0.29390755 |
94 | DAPK2 | 0.28583064 |
95 | NEK9 | 0.26860364 |
96 | STK24 | 0.25864103 |
97 | CAMKK1 | 0.25059867 |
98 | INSR | 0.24990251 |
99 | MAP3K12 | 0.23918168 |
100 | YES1 | 0.23851161 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Asthma_Homo sapiens_hsa05310 | 5.14872481 |
2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.84277600 |
3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.47202157 |
4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.44226605 |
5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.09052733 |
6 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.74207442 |
7 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.72872973 |
8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.14386844 |
9 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.90548962 |
10 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.86142631 |
11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.71383483 |
12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.31766683 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09412044 |
14 | * Tuberculosis_Homo sapiens_hsa05152 | 1.94092589 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84269599 |
16 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.73527672 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68462080 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61492611 |
19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56014200 |
20 | * Influenza A_Homo sapiens_hsa05164 | 1.54362838 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48216624 |
22 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.47161646 |
23 | * Phagosome_Homo sapiens_hsa04145 | 1.42751165 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41591349 |
25 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.41084826 |
26 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14807549 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.13202508 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.12517665 |
29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06024514 |
30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00384071 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96516707 |
32 | Malaria_Homo sapiens_hsa05144 | 0.93339502 |
33 | Measles_Homo sapiens_hsa05162 | 0.92838564 |
34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92374471 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89294479 |
36 | Legionellosis_Homo sapiens_hsa05134 | 0.85514055 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84196981 |
38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79663527 |
39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78579236 |
40 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74735302 |
41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74162085 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71396705 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71233991 |
44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69511196 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 0.66486924 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66438047 |
47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63495394 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 0.54931364 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.51435246 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.51396025 |
51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50507636 |
52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49669287 |
53 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.49329173 |
54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47631449 |
55 | Apoptosis_Homo sapiens_hsa04210 | 0.46065799 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 0.46058894 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45526875 |
58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37874960 |
59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34156187 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30965650 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30088533 |
62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29008256 |
63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28500986 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28233945 |
65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28038718 |
66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25781955 |
67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.25224227 |
68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20917547 |
69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20823146 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15188767 |
71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.14641852 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14348396 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14323096 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.13488798 |
75 | Endocytosis_Homo sapiens_hsa04144 | 0.11788416 |
76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11177933 |
77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11104118 |
78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10661317 |
79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08419437 |
80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08018134 |
81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07118375 |
82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.06096445 |
83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.05398813 |
84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.04264219 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.03338592 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.03051214 |
87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02636331 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02424055 |
89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.02085952 |
90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.02057486 |
91 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.01155262 |
92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.00938215 |
93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.00655472 |
94 | Prion diseases_Homo sapiens_hsa05020 | 0.00592019 |
95 | Mineral absorption_Homo sapiens_hsa04978 | 0.00473384 |
96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | -0.0199270 |
97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0175031 |
98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0064229 |
99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0037854 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0033065 |